SB 436
Comp
Drugs, Prescription - As enacted, adds mandating the use of biosimilar drugs as a cost-saving measure the bureau of TennCare may implement; adds that a health carrier, health benefit plan, or utilization review organization may require a patient to try a biosimilar product prior to providing coverage for the equivalent branded prescription drug; requires the TennCare pharmacy advisory committee to consider as a factor the use of biosimilar drugs in the committee's recommendation to the bureau of TennCare on any drugs to be added to the state preferred drug list. - Amends TCA Title 4; Title 53; Title 56; Title 68 and Title 71.
- Tennessee
- Senate
- Introduced Jan 28, 2025
- Session 114
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Tennessee’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
11 actions-
Comp. became Pub. Ch. 206
-
Companion House Bill substituted
-
Placed on Senate Regular Calendar for 3/31/2025
-
Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
-
Placed on Senate Commerce and Labor Committee calendar for 3/25/2025
-
Action deferred in Senate Commerce and Labor Committee to 3/25/2025
-
Placed on Senate Commerce and Labor Committee calendar for 3/18/2025
-
Placed on Senate Commerce and Labor Committee calendar for 3/18/2025
-
Passed on Second Consideration, refer to Senate Commerce and Labor Committee
-
Introduced, Passed on First Consideration
-
Filed for introduction